| Metric | H2 FY26 | H1 FY26 | H2 FY25 |
|---|---|---|---|
| Revenue from operations | 5.6 | 6.6 | 6.1 |
| Total income | 5.6 | 6.7 | 6.1 |
| Profit before exceptional items & tax | 0.0 | 0.3 | 0.5 |
| Profit before tax | 0.0 | 0.3 | 0.5 |
| Net profit | 0.0 | 0.2 | 0.4 |
| Operating margin | 0.0% | 4.5% | 8.2% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Revenue, year on year | -8.20% |
|---|
BSE results filing, NSE: KMS. Figures extracted from the filing.
More from KMS Medisurgi Ltd
All →Kms Medisurgi Financial Results
KMS Medisurgi Limited reported audited standalone financial results for the year ended March 31, 2026. The results include a qualified auditor's opinion regarding stock records and employee benefits.
Kms Medisurgi Board Meeting Date
KMS Medisurgi scheduled a board meeting for May 30, 2026, to approve annual audited financial results. Trading window remains closed until 48 hours post-announcement.
Kms Medisurgi Other Announcement
KMS Medisurgi Limited submitted a non-applicability declaration regarding corporate governance reports for the year ended March 31, 2026. As an SME-listed entity, the company is exempt from these specific SEBI LODR disclosure requirements under Regulation 15(2).
Kms Medisurgi Other Announcement
KMS Medisurgi Limited submitted a non-applicability disclosure regarding Related Party Transactions for the year ended March 31, 2026. The company is exempt under SEBI LODR Regulation 15(2) due to its listing on the BSE SME Platform and having paid-up capital and net worth below the specified regulatory thresholds.